<DOC>
	<DOC>NCT01348399</DOC>
	<brief_summary>The objective of this study is to evaluate effectiveness and safety of XIENCE PRIME stent in the "real world" daily practice as compared with other drug eluting stents (DESs)</brief_summary>
	<brief_title>Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)</brief_title>
	<detailed_description>This study is a non-randomized, prospective, open-label registry to compare the effectiveness and safety of XIENCE PRIME stents versus other DESs in patients with coronary artery disease.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients receiving XIENCE PRIME stents. The patient or guardian agrees to the study protocol and the schedule of clinical followup, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Patients with a mixture of other DESs Terminal illness with life expectancy &lt;1 year Patients presented with cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Coronary artery disease requiring drug eluting stents</keyword>
</DOC>